To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Safety Syringes Market size was valued at USD 8.45 billion in 2022 and is poised to grow from USD 9.11 billion in 2023 to USD 16.61 billion by 2031, growing at a CAGR of 7.8% in the forecast period (2024-2031).

The safety syringes market exhibits a competitive landscape characterized by the presence of several key players striving for market dominance. Companies such as Becton, Dickinson and Company, Medtronic plc, Terumo Corporation, Smiths Medical, and Retractable Technologies, Inc. are at the forefront of innovation and product development in this sector. 'Becton, Dickinson and Company (US)', 'Medtronic plc (US)', 'Terumo Corporation (Japan)', 'Smiths Medical (US)', 'Retractable Technologies, Inc. (US)', 'Gerresheimer AG (Germany)', 'Baxter International Inc. (US)', 'B. Braun Melsungen AG (Germany)', 'Cardinal Health, Inc. (US)', 'Nipro Corporation (Japan)', 'UltiMed, Inc. (US)', 'Revolutions Medical Corporation (US)', 'Axel Bio Corporation (US)', 'Gerresheimer AG (Germany)', 'HTL-STREFA S.A. (Poland)', 'DMC Medical Limited (UK)', 'Sol-Millennium Medical Group (South Korea)', 'Amcor plc (UK)', 'Bayer AG (Germany)', 'Vygon (France)'

Accidental needlestick injuries in healthcare settings carry a substantial threat to healthcare providers, potentially resulting in the transmission of bloodborne illnesses like HIV, hepatitis B, and hepatitis C. This increased recognition of the dangers associated with needlestick injuries has spurred a notable surge in the market for safety syringes. These specialized syringes are designed to effectively mitigate the risk of unintended needlestick injuries and their subsequent consequences.

Rise of Self-Injection and Home Healthcare: Patients are increasingly taking an active role in managing their conditions, and safety syringes equipped with user-friendly features are enabling safer and more convenient self-administration of medications at home. This trend aligns with the growing emphasis on patient empowerment, reducing healthcare facility visits, and improving overall treatment adherence.

North America currently stands as the dominating market in the safety syringes industry. The region's dominance can be attributed to stringent regulations regarding healthcare worker safety, well-established healthcare infrastructure, and higher awareness levels about the risks associated with needlestick injuries and bloodborne infections. Additionally, increased investments in research and development, along with a proactive approach to adopting advanced medical technologies, have further fueled the adoption of safety syringes.

Feedback From Our Clients

Global Safety Syringes Market

Product ID: SQMIG35B2132

$5,300
BUY NOW